ABSTRACTAn institutional-based cross-sectional study was conducted at the Laboratory Unit of the Kintampo Municipal Hospital among potential blood donors attending the laboratory for blood donation. The main objective of the study was to establish the utilization of Hepatitis B vaccination and its determinant factors among blood donors since vaccination is …
See more
ABSTRACTAn institutional-based cross-sectional study was conducted at the Laboratory Unit of the Kintampo Municipal Hospital among potential blood donors attending the laboratory for blood donation. The main objective of the study was to establish the utilization of Hepatitis B vaccination and its determinant factors among blood donors since vaccination is the key strategy for preventing transfusion transmitted infections. Cochrane formula was used to estimate the sample size of the population. In all 132 participants were used for the study assuming 10% non-response rate. A standard and individual structured questionnaire was used to gather data. Purposive sampling technique was used to recruit prospective blood donors resident in Kintampo North Municipality who visited the laboratory during the study period. Chi-Square was performed to establish relations between knowledge, perception and utilization of vaccination. Descriptive statistics tool was used for summarize different variables and presented them in graphs and tables. The statistical significant association between the variables was determined. The study found that, knowledge of HBV was low in the population understudy with Good (24.43%), Moderate (39.69%), and Poor (35.88%)). Majority (66.41%) had good perception about HBV. Utilization of HB Vaccination among respondents was very low (28.24%). There was significant association between education, occupation, participant’s knowledge on source of Hep B infection (UOR=3.33, CI:1.51-7.36, p<0.003), mode of transmission (UOR=2.47, CI:1.13-5.38, p<0.023), prevention (UOR=2.66, CI:1.00-7.05, p<0.048), the belief that there is a vaccine for Hep B infection (UOR=12.34, CI:1.60-94.90, p<0.016), Hep B-vaccine prevents Hep B (UOR=10.35, CI:1.33-80.07, p<0.025), and Hep B-vaccine is for adults (UOR=5.05, CI:1.43-17.80, p<0.012) at the univariate level and at 5% significant level 95 CI. However, the above variables were not statistically significant when they were adjusted for in a multiple logistic regression model. The study concludes that knowledge of Hepatitis B Virus infection was generally poor among blood donors. There was significant association between the general knowledge and utilization of hepatitis B vaccination. Therefore, the study recommends that the Ministry of Health should put in place measures to increase the knowledge of hepatitis B which will in turn improve the blood donors attitude towards hepatitis B virus infection and would ultimately increase the utilization of hepatitis B vaccination among the blood donors. A well-organized and sustained education programme on hepatitis B for blood donors is therefore an important success factor for the prevention of hepatitis B virus infection.
See less
